Skip to main content
OpenTrials

Clinical trial condition

Lymphoma, Non-Hodgkin

Explore clinical trials studying Lymphoma, Non-Hodgkin. Study availability and eligibility vary by location and protocol.

2,772 public trials 697 recruiting studies
Refine in advanced search Browse all conditions

Lymphoma, Non-Hodgkin trial results

Active, Not Recruiting

Rituximab and Lenalidomide vs Rituximab Alone as Maintenance After R-chemoterapy for Relapsed/Refractory FL Patients

NCT02390869

Conditions
Disease Attributes, Hemic and Lymphatic Diseases, Immune System Diseases, +11 more
Locations
  • ASST Grande Ospedale Metropolitano Niguarda Milan, MI, Italy
  • AUSL di Ravenna Ravenna, RA, Italy
  • Fondazione Del Piemonte Per L'Oncologia Ircc Di Candiolo Candiolo, Torino, Italy
  • Ospedale S. Giacomo di Castelfranco Veneto Castelfranco Veneto, Treviso, Italy
View all 28 locations
View Trial Details
Active, Not Recruiting

Ro Plus CHOEP as First Line Treatment Before HSCT in Young Patients With Nodal Peripheral T-cell Lymphomas

NCT02223208

Conditions
ALK- Anaplastic Large Cell Lymphoma (ALCL), Angioimmunoblastic T-cell Lymphoma (AITL), Hemic and Lymphatic Diseases, +15 more
Locations
  • Ospedale SS. Antonio e Biagio e Cesare Arrigo Alessandria, AL, Italy
  • Policlinico S. Orsola Malpighi Bologna, BO, Italy
  • Spedali Civili Brescia, BS, Italy
  • Ospedale Businco Cagliari, CA, Italy
View all 27 locations
View Trial Details
Active, Not Recruiting

Study of the Impact of CD34+ Cell Dose on Absolute Lymphocyte Count Following High-Dose Therapy and Autologous Stem Cell Transplantation for Relapsed and Refractory Diffuse Large B-cell Lymphoma (DLBCL)

NCT02570542

Conditions
Diffuse Large B-Cell Lymphoma (DLBCL), Hemic and Lymphatic Diseases, Immune System Diseases, +11 more
Locations
  • University of Nebraska Medical Center Omaha, Nebraska, United States
  • Memorial Sloan Kettering Basking Ridge (Consent and Follow-Up Only) Basking Ridge, New Jersey, United States
  • Memorial Sloan Kettering Monmouth (Consent and Follow up Only) Middletown, New Jersey, United States
  • Memorial Sloan Kettering Bergen (Consent and Follow Up Only) Montvale, New Jersey, United States
View all 14 locations
View Trial Details
Active, Not Recruiting

Personalized Risk Stratification Model of Follicular Lymphoma Patients

NCT03436602

Conditions
Follicular Lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +8 more
Locations
  • Arcispedale Santa Maria Nuova, AUSL IRCSS, Hematology Department Reggio Emilia, RE, Italy
  • Azienda Ospedaliera Universitaria Maggiore della Carità Novara, Italy
  • Institute of Oncology Research Bellinzona, Canton Ticino, Switzerland
  • Institute of Pathology Locarno, Canton Ticino, Switzerland
View Trial Details
Active, Not Recruiting

Brentuximab Vedotin and Combination Chemotherapy in Treating Patients With CD30-Positive Peripheral T-cell Lymphoma

NCT03113500

Conditions
Adult T-Cell Leukemia/Lymphoma, Anaplastic Large Cell Lymphoma, ALK-Positive, Anaplastic Large Cell Lymphoma, ALK-negative, +26 more
Locations
  • City of Hope Comprehensive Cancer Center Duarte, California, United States
  • Hackensack University Medical Center Hackensack, New Jersey, United States
  • Ohio State University Comprehensive Cancer Center Columbus, Ohio, United States
  • M D Anderson Cancer Center Houston, Texas, United States
View Trial Details

Related conditions